Document is current
Any future updates will be listed below
-
Authors
Yunusov, Emil
Piyade, Betul
Ergenc, Ilkay
Tasci, Muhammed Enes
Sariyar, Nisanur
Ozen Alahdab, Yesim
Atug, Ozlen
Kani, Haluk Tarik
- License Information
-
More Information
Article History
Received: 7 September 2025
Accepted: 2 April 2026
First Online: 21 April 2026
Declarations
:
: This study was approved by the Marmara University Faculty of Medicine Clinical Research Ethics Committee (approval no. 09.2025–25-0058, Istanbul, Türkiye). Due to the retrospective nature of the study and the use of anonymized patient data, the requirement for informed consent was waived by the Ethics Committee. The study was conducted in accordance with the Declaration of Helsinki.
: Not applicable.
: Haluk Tarik Kani has been speaker or advisor for Abbvie, Janssen, Sanofi and Takeda.
